2026
Does a full-body scan include a doctor?
A full-body MRI comes with a radiologist's report. A conversation with a doctor about that report is a separate line item, and the 14 full-body MRI operators Healthspan Economy records sell it both ways.
Notes, definitions, and findings on how AI search decides which health brands to cite, drawn from our research across longevity, women’s health, integrative medicine, and digital health.
2026
A full-body MRI comes with a radiologist's report. A conversation with a doctor about that report is a separate line item, and the 14 full-body MRI operators Healthspan Economy records sell it both ways.
2026
Healthspan Economy has 207 longevity and preventive operators on record, inside an atlas of 441 organizations filed under 48 countries. The count, what it covers and where the operators sit, read straight from the atlas.
2026
Healthspan Economy records 12 organizations in Canada. 8 hold a site in Toronto and 4 in Calgary. Neither federal law nor Ontario licenses a clinic as a longevity clinic, and one of the category's best-known names runs Canadian clinics without appearing in the Canada count.
2026
Healthspan Economy records 3 Qatari organizations in Doha: an executive health center run with Seoul's Asan Medical Center, a physician-led integrative clinic and a women's center inside a private hospital. Clinique La Prairie and Cenegenics also run Doha sites. A web search on September 29, 2026 returned launch coverage and nothing that lists them together.
2026
Healthspan Economy records 2 organizations in Panama: Livelong Clinic Panama and the practice of Dr Julio Effio, both in Panama City. Asked the same question, two AI assistants led with stem cell and regenerative clinics and cited no directory at all.
2026
Healthspan Economy records BDMS Wellness Clinic and VitalLife, the Bumrungrad subsidiary, with sites in Phuket, and both are units of Bangkok hospital groups. Phuket is too small to be a listed city on the Thailand page. Clinique La Prairie's Phuket resort is announced for November 2026. A web search on September 29, 2026 led with a booking marketplace's top five.
2026
Healthspan Economy records 7 organizations with a site in Riyadh, led by King Faisal Specialist Hospital's Department of Executive Health Medicine. A web search for the same question on September 29, 2026 returned press releases, operator pages and a regenerative medicine guide that names no clinic.
2026
Healthspan Economy records 5 organizations in Seoul: the health screening centers of Asan Medical Center, Samsung Medical Center and Severance Hospital, the Hanaro Medical Foundation and CHA's Chaum center. An English web search for the same question on September 29, 2026 named none of them.
2026
Mostly Dubai. Of the 38 UAE organizations Healthspan Economy records, 33 hold a site in Dubai and 5 in Abu Dhabi. Abu Dhabi is the emirate with a dedicated longevity clinic license, and the other five emirates are close to empty on the map.
2026
Healthspan Economy records 9 organizations in Tokyo. Most are the ningen dock, the one-day physician-read health examination, run by Keio, St. Luke's, Sanno and Tokyo Midtown Clinic, plus women's docks and regenerative medicine clinics in Ginza. The Tokyo guide a web search returned on September 29, 2026 names four other clinics and no hospital program.
2026
ARDD 2026 runs October 1-3 at the David Rubenstein Treehouse at Harvard University and online. The Copenhagen edition set for August was cancelled in March, and third-party calendars were still carrying it in September.
2026
Abu Dhabi licenses longevity medicine clinics under a standard in effect since April 2025. It makes conventional assessments mandatory, puts whole body MRI and DNA methylation in a needs-validation tier and sets staffing rules. Dubai has created an authority to license the field, but as of July 2026 it was not yet issuing clinic licenses.
2026
The Healthy Longevity Medicine Clinic Standard is the rare case of a regulator writing down what a longevity clinic has to do. Its mandatory diagnostic list is conventional internal medicine. Telomere length, liquid biopsies and senescent cell counts sit under Not Recommended outside of research protocol. IV NAD, IV stem cells, gene therapy, exosomes, plasmapheresis and hyperbaric oxygen are all coded Not Currently Applicable / Needs further data.
2026
A directory entry is a claim about a business on a particular day. Read seventeen of them twice, seventeen days apart, and three come out somewhere other than where they went in, while a fourth cannot be read on either day. The useful thing a record can publish is not the listing. It is the date it last looked.
2026
The Health Resort by Clinique La Prairie at Tri Vananda, Phuket, opening November 2026, and WellEra Bangkok, an approximately US$865 million BDMS and Capella development opening 2030, each describe themselves as the first of their kind in Southeast Asia. Both claims hold, because no register, standard or authority defines what a longevity destination is. This piece records what each party publishes, sets out the three distinctions that actually separate them and does not adjudicate.
2026
Two Italian instruments explain the shape of the country's private longevity market better than any commercial account of it. Article 8-ter types healthcare structures by delivery mode, so a longevity category has nowhere to sit. A 2015 ministerial decree confines non-routine advanced therapy medicinal products to research institutes, university hospital trusts and public hospitals, so a private clinic cannot lawfully supply them. Both are structural, and neither was written with longevity in mind.
2026
The longevity clinic category exists commercially and, in these four markets, not legally. Hong Kong regulates the premises under Cap. 633. Canada regulates whether a service may be billed to a patient. Thailand regulates what a facility may say about itself. Vietnam regulates the practitioner, on a five year cycle with a competency assessment phasing in. Compliance in one predicts nothing about the next.
2026
Seven of twenty-one famous consumer-diagnostics names clear the Atlas delivery bar. The pattern inside the seven is the story: Function bought an imaging company, WHOOP added clinician-reviewed labs to a strap, Levels put clinician review behind a $499 tier, and Oura and 23andMe never did any of it. The category is converting itself into healthcare one clinician at a time, and each conversion is datable.
2026
An eleven-city African discovery sweep in August 2026 found a genuine longevity-medicine cluster in Cape Town, unusually price-transparent for the category, and no qualifying clinic at all in Johannesburg. The Johannesburg zero is a finding reasoned against own-site evidence, not a gap in the research.
2026
A well-funded performance-longevity clinic closed its San Francisco and New York sites while franchises and platforms in the same category kept opening. The closure is not a verdict on demand. It is a verdict on a cost structure.
2026
Vietnam has a forming preventive-health market that English-only searching renders invisible. Six organizations are now on record, found by searching in Vietnamese as well as English.
2026
Four consumer-technology founders with no medical background have built or announced full-body scanning companies. The scan itself is collapsing in time and price, the newest entrant has no healthcare history at all, and the published evidence on screening asymptomatic people has not changed. The founder who built the clinical stack instead of the funnel closed after raising $13.25 million.
2026
Sweden has a small, Stockholm-heavy cluster of private preventive and longevity clinics, grown inside a country whose own evidence agency says screening healthy people has no scientific support. A map from the Atlas, not a shortlist, with the evidence and the regulators stated plainly.
2026
Full-body scanning is dropping fast in time and price, and an AI image company has announced a 60-second scanner it has not built. A cheaper scan finds more, which is not automatically good.
2026
When a longevity-branded batch is checked against what each operator actually delivers, a large share turns out to be wellness or aesthetics, not longevity medicine. The problem is scope, not honesty, and one regulator now draws the same line.
2026
Three biological-age services can return three different ages for the same body in the same season, because each runs a different clock against a different reference population. The defensible use is a trend inside one service, with the confidence placed in the raw biomarkers.
2026
An international group proposes that Italy's national health service measure healthspan as a public-health outcome, with a five-item agenda. It is a proposal, not an adopted policy, and the number it would track is a gap that is getting wider.
2026
An FDA panel backed six of seven peptides for compounding over the objection of the agency's own reviewers. The argument that carried the room was that people are buying these anyway, not that the evidence supports them.
2026
Function's $450 million from General Catalyst is not a funding round. It is revenue-share financing, and you cannot underwrite a business that way unless the payback is provable.
2026
Two of consumer longevity testing's best-funded companies are in federal court over what a biomarker is, and the category's published prices do not agree either. What a record can verify, and what it declines to assert.
2026
The UAE holds one of the densest clusters of longevity clinics in the world, and Abu Dhabi is the first place to license the category. A map from the Atlas, not a shortlist, with the evidence and the regulators stated plainly.
2026
In almost every market a longevity clinic is regulated not as a longevity clinic but as three separate things, a set of premises, a set of cell therapies and a set of tests, each answering to a different regulator. This piece compares what sixteen markets actually control, from primary instruments, and names where the record runs out.
2026
Singapore's most-discussed longevity and preventive-health clinics, ordered by community attention rather than our own ranking, with honest notes on cost, evidence, and what is still unproven.
2026
The healthspan economy is the industry forming around healthy years rather than total years: the clinics, platforms, diagnostics, and capital organized around extending the time people live in good health. Here is what it means, how it differs from longevity, and how large it has grown.
2026
A blood test, a supplement, a wearable, a clinic visit. For years the healthspan market sold these as standalone products. They are now assembling into stacks: connected systems where diagnostics, interpretation, intervention, and monitoring work as one. The stack, not the product, is becoming the unit of competition.
2026
Longevity is the headline. The healthspan economy is the market underneath it: a connected field of clinics, platforms, diagnostics, and capital that has outgrown the science-story framing it is usually given. Naming it as an economy changes what gets built and who gets cited.
2026
AEO, GEO, and GSO are three names for the same shift: getting cited inside AI answers rather than ranking in a list of links. The terminology has not settled. Here is what each one means, why it splintered, and which term a health brand should actually use.
2026
Three words for one ambition, often used interchangeably and rarely defined. Here is what each one means, how they relate, and why getting the distinction right is now a visibility question as much as a scientific one.
2026
AI search is not a black box so much as a system with observable rules. It retrieves sources, weighs their authority and cites a few. Knowing how that works explains why some clinics are cited constantly and others never appear.
2026
The 2026 AI Visibility Report tested 25 longevity clinics across four AI platforms and 200 query-platform observations. One pattern predicted citations more reliably than any other: clinics that publish their own question-matched content win, and clinics relying on press alone do not. It is also the one pattern a clinic can build deliberately.
2026
Abu Dhabi wrote the first rulebook for longevity medicine. Riyadh is funding the science at a scale no one else matches. The premium clinics are following. For Western operators, the question has shifted from whether to engage the Gulf to how.
2026
Search used to send people a list of links. AI search hands them an answer, and cites a few sources inside it. Answer engine optimization is the work of becoming one of those cited sources. Here is what it is and why it now matters more than ranking.
2026
In a study of 25 leading longevity clinics, three returned no results at all across four AI platforms and 200 query-platform observations. All three were premium-priced and well-regarded at home. Their disappearance is a warning about how AI search now decides who exists.
FAQ
Insights are working notes, definitions, and findings on how AI search decides which health brands to cite, drawn from our research across longevity, women’s health, integrative medicine, and digital health. They sit between the long-form reports and the Atlas: shorter, more frequent, and built to answer one question well.
New articles publish as the research produces them, typically several per month while a report cycle is active. The RSS feed at /insights/rss.xml carries every new piece.
Every article is free to cite with attribution to Healthspan Economy and a link to the original. For republishing or syndication, write to [email protected].